DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 12Dr. Reddy's Laboratories
02 2Actavis Inc
03 4Alembic Pharmaceuticals Limited
04 1Amneal Pharmaceuticals
05 1Amoli Organics
06 1Amomed Pharma Gmbh
07 1Amphastar Pharmaceuticals
08 4Ferrer Internacional
09 4Ferrer International, Sa.
10 4Gebro Pharma
11 4Ideogen Ag
12 4Liquidia Corporation
13 2Medartuum
14 4ORIFARM GROUP AS
15 4OrPha Swiss
16 4Orpha-Devel Trading And Sales Gmbh
17 4PH HEALTH
18 1Paranova Pharmaceuticals Ab
19 4Sandoz B2B
20 4Scipharm S.A.R.L.
21 4Scipharm S?rl
22 4Teva Pharmaceutical Industries
23 4Tillomed Laboratories Ltd
24 30United Therapeutics
25 4Zentiva
01 28INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
02 39Infusion Solution
03 4Infusion fluid, resolution
04 4Injection
05 9POWDER;INHALATION
06 12Perfusion Solution
07 4SOLUTION
08 1SOLUTION;INHALATION
09 4SOLUTION;INTRAVENOUS, SUBCUTANEOUS
10 4Solution For Perfusion
11 2TABLET, EXTENDED RELEASE;ORAL
12 1Treprostinil 100Mg 20Ml 1 Units Parenteral Use
13 1Treprostinil 200Mg 20Ml 1 Units Parenteral Use
14 1Treprostinil 20Mg 20Ml 1 Units Parenteral Use
15 1Treprostinil 50Mg 20Ml 1 Units Parenteral Use
01 12Allowed
02 20Approved
03 16Authorized
04 7DISCN
05 7Deregistered
06 4Lead Market Dossiers- Filed
07 4Prescription
08 35RX
09 10Blank
01 16REMODULIN
02 23Remodulin
03 22TREPROSTINIL
04 1TYVASO
05 5TYVASO DPI
06 4Treprostinil Ferrer
07 4Treprostinil Ideogen
08 4Treprostinil Orpha
09 4Treprostinil Reddy
10 4Treprostinil Tillomed
11 4Treprostinilo Zentiva
12 8Trepulmix
13 8Tresuvi
14 4YUTREPIA
15 4Blank
01 4Canada
02 4India
03 4Italy
04 4Norway
05 16Spain
06 27Sweden
07 12Switzerland
08 44USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength : 1mg/ml
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000055
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength : 10mg/ml
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000086
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength : 2.5mg/ml
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000062
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength :
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000079
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2021-07-30
Application Number : 21272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 0.1MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 0.2MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 0.4MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
